Rhythm Pharmaceuticals, Inc. (RYTM)
92.57
-0.50
(-0.54%)
USD |
NASDAQ |
Oct 30, 16:00
92.61
+0.04
(+0.04%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Operations (Quarterly) : -9.152M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.152M |
| March 31, 2026 | -44.18M |
| December 31, 2025 | -25.39M |
| September 30, 2025 | -26.62M |
| June 30, 2025 | -23.31M |
| March 31, 2025 | -40.35M |
| December 31, 2024 | -18.84M |
| September 30, 2024 | -25.22M |
| June 30, 2024 | -29.08M |
| March 31, 2024 | -40.74M |
| December 31, 2023 | -29.38M |
| September 30, 2023 | -29.25M |
| June 30, 2023 | -41.09M |
| March 31, 2023 | -36.43M |
| December 31, 2022 | -34.00M |
| September 30, 2022 | -46.99M |
| June 30, 2022 | -38.81M |
| March 31, 2022 | -53.63M |
| December 31, 2021 | -40.47M |
| September 30, 2021 | -40.16M |
| June 30, 2021 | -31.84M |
| March 31, 2021 | -33.53M |
| Date | Value |
|---|---|
| December 31, 2020 | -29.12M |
| September 30, 2020 | -27.03M |
| June 30, 2020 | -29.73M |
| March 31, 2020 | -36.10M |
| December 31, 2019 | -32.22M |
| September 30, 2019 | -33.60M |
| June 30, 2019 | -25.55M |
| March 31, 2019 | -31.38M |
| December 31, 2018 | -20.98M |
| September 30, 2018 | -16.94M |
| June 30, 2018 | -12.48M |
| March 31, 2018 | -11.65M |
| December 31, 2017 | -7.885M |
| September 30, 2017 | -8.417M |
| June 30, 2017 | -6.142M |
| March 31, 2017 | -7.016M |
| December 31, 2016 | |
| September 30, 2016 | -4.443M |
| June 30, 2016 | -6.21M |
| March 31, 2016 | -6.387M |
| December 31, 2015 | -3.436M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 168.11M |
| Cytokinetics, Inc. | -159.84M |
| Exelixis, Inc. | 307.74M |
| Ionis Pharmaceuticals, Inc. | 565.53M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 14.01M |
| Cash from Financing (Quarterly) | -1.165M |
| Free Cash Flow | -146.30M |
| Free Cash Flow Per Share (Quarterly) | -0.1334 |
| Free Cash Flow to Equity (Quarterly) | 108.08M |
| Free Cash Flow to Firm (Quarterly) | -4.571M |
| Free Cash Flow Yield | -2.34% |